Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Medicus Pharma Ltd (MDCX.VN)

Medicus Pharma Ltd (MDCX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 35,538
  • Shares Outstanding, K 16,153
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,784 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 32.43
Trade MDCX.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.97
  • Most Recent Earnings $-0.18 on N/A
  • Next Earnings Date 04/03/24
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.100 +4.76%
on 05/03/24
2.490 -11.65%
on 04/16/24
-0.020 (-0.90%)
since 04/15/24
3-Month
2.100 +4.76%
on 05/03/24
2.750 -20.00%
on 02/16/24
-0.300 (-12.00%)
since 02/15/24

Most Recent Stories

More News
Medicus Pharma Ltd. Announces Closing of Private Placement of Convertible Notes

Toronto, Ontario--(Newsfile Corp. - May 3, 2024) - Medicus Pharma Ltd. (TSXV: MDCX) (FSE: N46) (the "Company") is pleased to announce that it has completed the first closing of its previously announced...

MDCX.VN : 2.200 (+1.38%)
Medicus Pharma Ltd. Announces Proposed Private Placement of Convertible Notes

Toronto, Ontario--(Newsfile Corp. - April 25, 2024) - Medicus Pharma Ltd. (TSXV: MDCX) (FSE: N46) (the "Company") is pleased to announce that it intends to complete the first closing of a private placement...

MDCX.VN : 2.200 (+1.38%)
Medicus Pharma Ltd. Receives FDA Comments on Phase 2 Clinical Protocol to Non-Invasively Treat Basal Cell Carcinoma of the Skin

FDA Agrees with the Study Design of Randomizing Up To 60 Participants with Nodular Type of Basal Cell CarcinomaToronto, Ontario--(Newsfile Corp. - March 21, 2024) - Medicus Pharma Ltd. (TSXV: MDCX) (FSE:...

MDCX.VN : 2.200 (+1.38%)
Medicus Pharma Ltd. Announces Appointment of Erica Monaco as Chief Operating Officer

Provides Corporate Update on Financing and Investor RelationsToronto, Ontario--(Newsfile Corp. - March 5, 2024) - Medicus Pharma Ltd. (TSXV: MDCX) (FSE: N46) ("Medicus" or the "Company") is pleased to...

MDCX.VN : 2.200 (+1.38%)
Medicus Pharma Ltd. Publishes Phase 1 Clinical Study Report Demonstrating Safety & Tolerability in All Participants with Basal Cell Carcinoma

The Clinical Study Report Also Describes Efficacy in 6 ParticipantsToronto, Ontario--(Newsfile Corp. - February 15, 2024) - Medicus Pharma Ltd. (TSXV: MDCX) (FSE: N46) ("Medicus" or the "Company") is pleased...

MDCX.VN : 2.200 (+1.38%)
Medicus Pharma Ltd. Announces the Filing of a Final Base Shelf Prospectus

Toronto, Ontario--(Newsfile Corp. - January 25, 2024) - Medicus Pharma Ltd. (TSXV: MDCX) ("Medicus" or the "Company") has filed a final short form base shelf prospectus (the "Shelf Prospectus") with the...

MDCX.VN : 2.200 (+1.38%)
Medicus Pharma Ltd. Announces Listing on Frankfurt Stock Exchange

Toronto, Ontario--(Newsfile Corp. - January 18, 2024) - Medicus Pharma Ltd. (TSXV: MDCX) (FSE: N46) ("Medicus" or the "Company") is pleased to announce the listing of its common shares on the Frankfurt...

MDCX.VN : 2.200 (+1.38%)
Medicus Pharma Ltd. Submits to the FDA Phase 2 IND Clinical Protocol to Non-Invasively Treat Basal Cell Carcinoma of the Skin

The Clinical Study Is Expected to Randomize Up to 60 PatientsToronto, Ontario--(Newsfile Corp. - January 3, 2024) - Medicus Pharma Ltd. (TSXV: MDCX) ("Medicus" or the "Company") is pleased to announce...

MDCX.VN : 2.200 (+1.38%)
Medicus Pharma Opens the Market

/CNW/ - Raza Bokhari, MD, Executive Chairman and Chief Executive Officer, Medicus Pharma Ltd. ("Medicus" or the "Company") (TSXV: MDCX), and his team joined...

MDCX.VN : 2.200 (+1.38%)
Medicus Pharma Ltd. to Ring the Toronto Stock Exchange Opening Bell on Thursday October 26th 2023; Appoints Paul A. Marchetto, MD, FACS as Chairman of the Scientific Advisory Board

Toronto, Ontario--(Newsfile Corp. - October 25, 2023) - Medicus Pharma Ltd. (TSXV: MDCX) ("Medicus" or the "Company") is pleased to announce that Executive Chairman and CEO Dr. Raza Bokhari, along with...

MDCX.VN : 2.200 (+1.38%)

Business Summary

Medicus Pharma Ltd will carry on the business of pharmaceutical drug development focused initially on SkinJect. The objective of SkinJect is developing and commercializing novel microneedle arrays for the purpose of treating certain skin cancers, initially basal cell carcinoma.

See More

Key Turning Points

3rd Resistance Point 2.200
2nd Resistance Point 2.200
1st Resistance Point 2.200
Last Price 2.200
1st Support Level 2.200
2nd Support Level 2.200
3rd Support Level 2.200

See More

52-Week High 3.050
Last Price 2.200
Fibonacci 61.8% 2.003
Fibonacci 50% 1.680
Fibonacci 38.2% 1.357
52-Week Low 0.310

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar